Features
Pricing
Events
Reg.News
Short Interest
Explore Content
- Explore
  - Providers
    
    Providers
    
    Free/Commissioned
    
    High Net Worth Offering
    
    Institutional Offering
    
    Free/Commissioned
    
    Research that is free to access for all investors. Companies commission these providers to write research about them.
    View Research
    
    What is our Main Bundle Offering?
    
    Brokers who write research on their corporate clients and make it available through our main bundle offering.
    View Research
    
    What is Institutional?
    
    Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
    View Research
  - Regions
    
    Regions
    
    UK
    
    Rest of EMEA
    
    N America
    
    APAC
    
    LatAm
  - Exchanges
    
    Exchanges
    
    Aquis Apex
    
    Australian Securities Exchange
    
    Canadian Securities Exchange
    
    Euronext Paris
    
    London Stock Exchange (domestic)
    
    SIX Swiss Exchange
  - Sectors
    
    Sector Coverage
    
    Building & Construction
    
    Discretionary Personal Goods
    
    Discretionary Retail
    
    Energy
    
    Health
    
    Investment Trusts
    
    Media
    
    Resources
    
    Technology
  - Small / Large Cap
    
    Small / Large Cap
    
    UK100
    
    UK250
    
    UK Smallcap
    
    UK Other Main Markets
    
    Other
Login
Sign Up

LIVE

Event in Progress:

Join Here ×

15 Jan 2024

Two steps forward, one step back

Borregaard ASA (BRG:OSL), 0 | BORREGAARD (BRG:STO), 0 | Huhtamaki Oyj (HUH1V:HEL), 0 | Huhtamaki India Limited (509820:BOM), 0 | Essity Aktiebolag-A (ESSITYA:STO), 0 | Essity AB Class B (ESSITY.B:OME), 0 | Stora Enso Oyj Class R (STERV:HEL), 0 | Elopak ASA (ELO:OSL), 0 | Scandic Hotels Group (SHOT:STO), 0 | Scandinavian Brake Systems (SBS:CPH), 0 | Scandinavian Chemotech Ab (CMOTECB:STO), 0 | SCANDIDOS (SDOS:STO), 0 | SCANSOURCE (SCSC:NYSE), 0 | Scandi Standard (SCST:STO), 0 | Scandinavian Health Innovati (SANNAB:STO), 0 | SCANDINAVIAN ENVIRO SYSTEMS (SES:STO), 0 | Scandion Oncology A/S (SCOL:STO), 0 | Scanfil Oyj (SCANFL:HEL), 0 | SCATEC SOLAR (SSO:STO), 0 | Scandion Oncology A/S (SCOL:OME), 0 | Scatec ASA (SCATC:OSL), 0 | Scandinavian House Development (MLSHD:EPA), 0 | SCALA DEVELOPMENT S.A. (NCHI:BSE), 0 | Scandium International Mining Corp. (SCY:TSX), 0 | Scandi Standard AB (SCST:OME), 0 | SCANDINAVIAN REAL HEART (HEART:STO), 0 | Scandinavian Tobacco Group A (STG:CPH), 0 | ScandiDos AB (SDOS:OME), 0 | Scandinavian Investment Group A/S (SIG:CSE), 0 | Scandinavian Private Equity (SPEAS:CPH), 0 | Scandinavian Tobacco Group A/S (STG:CSE), 0 | Scape Technologies A/S (SCAPE:CPH), 0 | SCANDBOOK (SBOK:STO), 0 | ScanSource, Inc. (SCSC:NAS), 0 | Matador Technologies Inc. (MATA:TSX), 0 | Scancell Holdings Plc (SCLP:LON), 9.2 | Scancom Plc (MTNGH:GHA), 0 | Scarnose International Ltd. (543537:BOM), 0 | Scandic Hotels Group AB (SHOT:OME), 0 | Scana ASA (SCANA:OSL), 0 | Scan Steels Ltd (511672:BOM), 0 | Scan Projects Ltd. (531797:BOM), 0 | SGL Resources Ltd (526544:BOM), 0 | Scandinavian Medical Solutions A/S (SMSMED:CSE), 0 | SCAT Inc. (3974:TKS), 0 | Scala, Inc. (4845:TKS), 0 | Scales Corp. Ltd. (SCL:NZE), 0 | Scanwolf Corp. Bhd. (7239:KLS), 0 | Scancode AS (SCOD:STO), 0 | Scandinavian ChemoTech AB Class B (CMOTEC.B:OME), 0 | ScandBook Holding AB (SBOK:OME), 0 | Scandinavian Enviro Systems AB (SES:OME), 0 | Scan Inter Public Company Ltd (SCN:BKK), 0 | Scan-D Corporation (6195:ROCO), 0 | Scandia Incorporated (SDNI:OTC), 0 | Scanway Spolka Akcyjna (SCW:WAR), 0 | Scandinavian Real Heart AB (7820:FRA), 0 | Norske Skog ASA (NSKOG:STO), 0 | Norske Skog ASA (NSKOG:OSL), 0 | UPM-Kymmene Oyj (UPM:HEL), 0 | Nordic Paper Holding AB (NPAPER:OME), 0 | Holmen AB Class B (HOLM.B:OME), 0 | Holmen Ab-B Shares (HOLMB:STO), 0 | BillerudKorsnas (BILL:STO), 0 | Billerud AB (BILL:OME), 0 | Scandinavian Astor Group AB (Y73:FRA), 0

- ABGSC Pulp & Paper Research | Martin Melbye | Ali Shemmari
- 162 pages

Price hike efforts on early-cyclicals. Q4e EBIT down q-o-q, seasonality and prices. Finding the best players LT - smart to buy when macro is low.

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers

Already a member? Log in here

Two steps forward, one step back

Borregaard ASA (BRG:OSL), 0 | BORREGAARD (BRG:STO), 0 | Huhtamaki Oyj (HUH1V:HEL), 0 | Huhtamaki India Limited (509820:BOM), 0 | Essity Aktiebolag-A (ESSITYA:STO), 0 | Essity AB Class B (ESSITY.B:OME), 0 | Stora Enso Oyj Class R (STERV:HEL), 0 | Elopak ASA (ELO:OSL), 0 | Scandic Hotels Group (SHOT:STO), 0 | Scandinavian Brake Systems (SBS:CPH), 0 | Scandinavian Chemotech Ab (CMOTECB:STO), 0 | SCANDIDOS (SDOS:STO), 0 | SCANSOURCE (SCSC:NYSE), 0 | Scandi Standard (SCST:STO), 0 | Scandinavian Health Innovati (SANNAB:STO), 0 | SCANDINAVIAN ENVIRO SYSTEMS (SES:STO), 0 | Scandion Oncology A/S (SCOL:STO), 0 | Scanfil Oyj (SCANFL:HEL), 0 | SCATEC SOLAR (SSO:STO), 0 | Scandion Oncology A/S (SCOL:OME), 0 | Scatec ASA (SCATC:OSL), 0 | Scandinavian House Development (MLSHD:EPA), 0 | SCALA DEVELOPMENT S.A. (NCHI:BSE), 0 | Scandium International Mining Corp. (SCY:TSX), 0 | Scandi Standard AB (SCST:OME), 0 | SCANDINAVIAN REAL HEART (HEART:STO), 0 | Scandinavian Tobacco Group A (STG:CPH), 0 | ScandiDos AB (SDOS:OME), 0 | Scandinavian Investment Group A/S (SIG:CSE), 0 | Scandinavian Private Equity (SPEAS:CPH), 0 | Scandinavian Tobacco Group A/S (STG:CSE), 0 | Scape Technologies A/S (SCAPE:CPH), 0 | SCANDBOOK (SBOK:STO), 0 | ScanSource, Inc. (SCSC:NAS), 0 | Matador Technologies Inc. (MATA:TSX), 0 | Scancell Holdings Plc (SCLP:LON), 9.2 | Scancom Plc (MTNGH:GHA), 0 | Scarnose International Ltd. (543537:BOM), 0 | Scandic Hotels Group AB (SHOT:OME), 0 | Scana ASA (SCANA:OSL), 0 | Scan Steels Ltd (511672:BOM), 0 | Scan Projects Ltd. (531797:BOM), 0 | SGL Resources Ltd (526544:BOM), 0 | Scandinavian Medical Solutions A/S (SMSMED:CSE), 0 | SCAT Inc. (3974:TKS), 0 | Scala, Inc. (4845:TKS), 0 | Scales Corp. Ltd. (SCL:NZE), 0 | Scanwolf Corp. Bhd. (7239:KLS), 0 | Scancode AS (SCOD:STO), 0 | Scandinavian ChemoTech AB Class B (CMOTEC.B:OME), 0 | ScandBook Holding AB (SBOK:OME), 0 | Scandinavian Enviro Systems AB (SES:OME), 0 | Scan Inter Public Company Ltd (SCN:BKK), 0 | Scan-D Corporation (6195:ROCO), 0 | Scandia Incorporated (SDNI:OTC), 0 | Scanway Spolka Akcyjna (SCW:WAR), 0 | Scandinavian Real Heart AB (7820:FRA), 0 | Norske Skog ASA (NSKOG:STO), 0 | Norske Skog ASA (NSKOG:OSL), 0 | UPM-Kymmene Oyj (UPM:HEL), 0 | Nordic Paper Holding AB (NPAPER:OME), 0 | Holmen AB Class B (HOLM.B:OME), 0 | Holmen Ab-B Shares (HOLMB:STO), 0 | BillerudKorsnas (BILL:STO), 0 | Billerud AB (BILL:OME), 0 | Scandinavian Astor Group AB (Y73:FRA), 0

Published: 15 Jan 2024
Author: ABGSC Pulp & Paper Research | Martin Melbye | Ali Shemmari
Pages: 162

Price hike efforts on early-cyclicals. Q4e EBIT down q-o-q, seasonality and prices. Finding the best players LT - smart to buy when macro is low.

More Content

More Content

May: Pulp shipments -1.7% y-o-y

Companies: NSKOG BILL SCAB SCAB HOLMB BRG BRG HUH1V METSB STERV UPM NSKOG ESSITYB HOLMB NPAPER BILL ELO

Most popular equity research this week | 30 Apr - 4 May

Companies: BNO0RXAVONCMHCHHRE/SCEMPACNICLARBBSIXHTONMURAGYGOALCKTRTNCLIGMARSINLGDRCVSGTRXSCLPBAGCOSABDPTIMEAVODNLOXBKOOVVALYGENABZANSFTCFGTLYPHPAVCTMCLACRLGYMBURDVLPLUSDEBSDPZMMX

SEK 320m capital increase to stem growth; chg. est. & PT

Companies: Scandinavian Astor Group AB

Most popular equity research this week | 30 Jul - 3 Aug

Companies: BNOWJASEE0RXCMHRE/SCELGENCMSARBBSIXHTONMURAGYCLIGINLGDRTRXSCLPCAMLCOSTIMEAVODNLOXBGETBKOOVVALYGENABZANSFTCFGTLYW7LPHPAVCTMCLBURDVLXPP

PANMURE LIBERUM: Scancell Holdings: Clinical data expected July

Companies: Scancell Holdings Plc

Research Tree

Useful Links

Features
Pricing
RNS/Newswires Feeds
Providers Hub
Company Hub
Stock Pick League
Chrome Extension
iOS and Android Apps

Account

Login
Join Now
Contact

Follow us on Linkedin
Follow us on X

© Research Tree 2025

Terms of Service
Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top

Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Providers
Contact
Sign Up
Sign In